Lamivudine and Dolutegravir
- Generic Name
- Lamivudine and Dolutegravir
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Indication
用于治疗感染人类免疫缺陷病毒1型(HIV-1)的成人和12岁以上青少年（体重至少40kg），且对整合酶抑制剂或拉米夫定无已知或可疑耐药患者。
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath